Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza

Delivering rapid protection against infectious agents to non-immune populations is a formidable public health challenge. Although passive immunotherapy is a fast and effective method of protection, large-scale production and administration of monoclonal antibodies (mAbs) is expensive and unpractical...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelini, Zuleika, Minkoff, Judith M., Yang, Jianjun, Negri, Donatella, Cara, Andrea, Hanson, Brendon J., Salvatore, Mirella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767071/
https://www.ncbi.nlm.nih.gov/pubmed/33348840
http://dx.doi.org/10.3390/v12121460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767071/
https://www.ncbi.nlm.nih.gov/pubmed/33348840
http://dx.doi.org/10.3390/v12121460

Ejemplares similares